ID

16622

Description

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Screening Assessments

Lien

https://clinicaltrials.gov/ct2/show/NCT00373425

Mots-clés

Versions (2)
  1. 27/07/2016 27/07/2016 -
  2. 01/08/2016 01/08/2016 -
Téléchargé le

27 juillet 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT) NCT00373425

Anglais

Test Screening Assessments NCT00373425

1 Formulaires  
Header
Description

Header

Site Number
Description

Site number

Type de données

integer

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Description

Patient Number

Type de données

integer

Alias
UMLS CUI [1]
C1830427
Patient Initials
Description

Patient Initials

Type de données

text

Alias
UMLS CUI [1]
C2986440
Demographics
Description

Demographics

Date of birth
Description

Date of birth

Type de données

date

Alias
UMLS CUI [1]
C0421451
Gender
Description

Gender

Type de données

integer

Alias
UMLS CUI [1]
C0079399
Ethnicity
Description

Ethnicity

Type de données

integer

Alias
UMLS CUI [1]
C0015031
Race
Description

Race

Type de données

integer

Alias
UMLS CUI [1]
C0034510
If other, specify
Description

Race

Type de données

text

Alias
UMLS CUI [1]
C0034510
Screening Eligibility Criteria
Description

Screening Eligibility Criteria

Did the patient meet all of the screening inclusion criteria?
Description

Inclusion Criteria

Type de données

boolean

Alias
UMLS CUI [1]
C1512693
lf No, which was/were not met? Inclusion Letter(s):
Description

Inclusion Criteria

Type de données

text

Alias
UMLS CUI [1]
C1512693
Did the patient meet any of the screening exclusion criteria?
Description

Exclusion Criteria

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
If Yes, which was/were met? Exclusion Letter(s):
Description

Exclusion Criteria

Type de données

text

Alias
UMLS CUI [1]
C0680251
lf any screening eligibility criteria were not met, was an exemption granted by OSI?
Description

Eligibility Criteria

Type de données

integer

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348482
Date screening consent was signed:
Description

Date screening consent was signed

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0021430
IVRS Screening Number
Description

IVRS Screening Number

Type de données

text

Alias
UMLS CUI [1]
C1710477
Treatment Eligibility Criteria
Description

Treatment Eligibility Criteria

Did the patient meet all of the treatment inclusion criteria?
Description

Inclusion Criteria

Type de données

boolean

Alias
UMLS CUI [1]
C1512693
lf No, which was/were not met? Inclusion Number(s):
Description

Inclusion Criteria

Type de données

text

Alias
UMLS CUI [1]
C1512693
Did the patient meet any of the treatment exclusion criteria?
Description

Exclusion Criteria

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
If Yes, which was/were met? Exclusion Number(s):
Description

Exclusion Criteria

Type de données

text

Alias
UMLS CUI [1]
C0680251
lf any treatment eligibility criteria were not met, was an exemption granted by OSI?
Description

Eligibility Criteria

Type de données

integer

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348482
Date main study consent was signed:
Description

Date main study consent was signed

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0021430
IVRS Randomization
Description

IVRS Randomization

Date randomized through IVRS (Study drug therapy must start within 5 days of randomization.):
Description

Randomization Date

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0034656
Retour au début de la page

Similar models

Test Screening Assessments NCT00373425

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Header
Site number
Item
Site Number
integer
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Demographics
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
integer
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Ethnicity
integer
C0015031 (UMLS CUI [1])
Ethnicity
Code List
Ethnicity
CL Item
Hispanic/Latino (1)
CL Item
Not Hispanic/Latino (2)
Item
Race
integer
C0034510 (UMLS CUI [1])
Ethnicity
Code List
Race
CL Item
American Indian/Alaska Native (1)
CL Item
Asian: Far East (2)
CL Item
Asian: Southeast Asia (3)
CL Item
Asian: Indian Subcontinent (4)
CL Item
Black (5)
CL Item
Native Hawaiian/Pacific Islander (6)
CL Item
White (7)
CL Item
Other (8)
Race
Item
If other, specify
text
C0034510 (UMLS CUI [1])
Item Group
Screening Eligibility Criteria
Inclusion Criteria
Item
Did the patient meet all of the screening inclusion criteria?
boolean
C1512693 (UMLS CUI [1])
Inclusion Criteria
Item
lf No, which was/were not met? Inclusion Letter(s):
text
C1512693 (UMLS CUI [1])
Exclusion Criteria
Item
Did the patient meet any of the screening exclusion criteria?
boolean
C0680251 (UMLS CUI [1])
Exclusion Criteria
Item
If Yes, which was/were met? Exclusion Letter(s):
text
C0680251 (UMLS CUI [1])
Item
lf any screening eligibility criteria were not met, was an exemption granted by OSI?
integer
C1516637 (UMLS CUI [1,1])
C2348482 (UMLS CUI [1,2])
Eligibility Criteria
Code List
lf any screening eligibility criteria were not met, was an exemption granted by OSI?
CL Item
Yes (1)
CL Item
No (2)
CL Item
NA (3)
Date screening consent was signed
Item
Date screening consent was signed:
date
C0011008 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
IVRS Screening Number
Item
IVRS Screening Number
text
C1710477 (UMLS CUI [1])
Item Group
Treatment Eligibility Criteria
Inclusion Criteria
Item
Did the patient meet all of the treatment inclusion criteria?
boolean
C1512693 (UMLS CUI [1])
Inclusion Criteria
Item
lf No, which was/were not met? Inclusion Number(s):
text
C1512693 (UMLS CUI [1])
Exclusion Criteria
Item
Did the patient meet any of the treatment exclusion criteria?
boolean
C0680251 (UMLS CUI [1])
Exclusion Criteria
Item
If Yes, which was/were met? Exclusion Number(s):
text
C0680251 (UMLS CUI [1])
Item
lf any treatment eligibility criteria were not met, was an exemption granted by OSI?
integer
C1516637 (UMLS CUI [1,1])
C2348482 (UMLS CUI [1,2])
Eligibility Criteria
Code List
lf any treatment eligibility criteria were not met, was an exemption granted by OSI?
CL Item
Yes (1)
CL Item
No (2)
CL Item
NA (3)
Date main study consent was signed
Item
Date main study consent was signed:
date
C0011008 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Item Group
IVRS Randomization
Randomization Date
Item
Date randomized through IVRS (Study drug therapy must start within 5 days of randomization.):
date
C0011008 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial